In this study, we demonstrate that glioma tissues and glioblastoma cells with high expression levels of DYRK1A exhibit strong NFATC1 activity, revealing a remarkably positive correlation between DYRK1A and NFATC1. The gene discussed is NFATC1; the disease is central nervous system cancer.